SIMCERE PHARMA (02096.HK) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec19

Simcere Pharma Advances Innovation 2.0, Focusing on Original New Drug Development

07:56

Dec15

CITIC Securities Maintains 'Buy' Rating for Xian Shen Pharmaceutical, with a Target Price of HKD 20.16

05:07

Guo Jin Securities Gives Buy Rating to Simcere Pharmaceutical

01:18

Dec7

Xiansheng Pharma's Ensuzhu® Included in National Medical Insurance Directory, Endu® Renewal Completed

23:12

Dec3

Wangsan Wangshui Grants Xiansheng Pharmaceutical Exclusive License for New Indications of VV116

08:35

Vigonvita Life Science Grants Xian-Janssen Exclusivity on VV116 for New Indications

08:30

Schedules & Filings

Schedules

Filings

Aug21

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 1.962 B, Net Income 330.33 M, EPS 0.1351

Jul14

Distribution Plan(CST)

Cash dividend 0.1748 HKD

Jun19

Distribution Plan(CST)

Cash dividend 0.1748 HKD

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change